ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.26
-1.01%
US Tech 100
17,950.79
-0.43%
S&P 500
5,239.73
-0.72%
US Dollar vs CAD
1.36446
-0.06%
Bitcoin
69,052.22
1.93%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Roquefort Therapeutics Plc (ROQ)

  7. Roquefort Therapeutics Plc (ROQ) News

ROQ

Roquefort Therapeutics (ROQ)

Roquefort Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:ROQ
DateTimeSourceHeadlineSymbolCompany
05/23/20243:25PMAlliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
05/23/20243:25PMAlliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
05/23/20241:05AMRNS Regulatory NewsRoquefort Therapeutics PLC Issue of Convertible Loan Notes & Board ChangesLSE:ROQRoquefort Therapeutics Plc
05/23/20241:00AMRNS Regulatory NewsRoquefort Therapeutics PLC Midkine Antibody Licencing DealLSE:ROQRoquefort Therapeutics Plc
04/26/20242:59PMAlliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
04/26/20242:59PMAlliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
04/26/20241:00AMRNS Regulatory NewsRoquefort Therapeutics PLC Annual Report & Financial Statements - 31 Dec 2023LSE:ROQRoquefort Therapeutics Plc
04/05/20246:32AMAlliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
04/05/20246:32AMAlliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
04/05/20241:00AMRNS Regulatory NewsRoquefort Therapeutics PLC Response to Share Price MovementLSE:ROQRoquefort Therapeutics Plc
03/11/20246:12AMAlliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
03/11/20246:12AMAlliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
03/11/20242:00AMRNS Regulatory NewsRoquefort Therapeutics PLC Positive Results: Midkine mRNA and STAT-6 siRNALSE:ROQRoquefort Therapeutics Plc
02/06/202410:50AMAlliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
02/06/202410:50AMAlliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
02/06/20241:00AMRNS Regulatory NewsRoquefort Therapeutics PLC Operations UpdateLSE:ROQRoquefort Therapeutics Plc
11/24/20231:00AMUK RegulatoryRoquefort Therapeutics PLC Change of AuditorLSE:ROQRoquefort Therapeutics Plc
11/06/20236:01AMAlliance NewsAlliance NewsRoquefort Therapeutics MK cell programme shows positive resultsLSE:ROQRoquefort Therapeutics Plc
11/06/20236:01AMAlliance NewsAlliance NewsRoquefort Therapeutics MK cell programme shows positive resultsLSE:ROQRoquefort Therapeutics Plc
11/06/20231:00AMUK RegulatoryRoquefort Therapeutics PLC Significant Mesodermal Killer Cell MilestoneLSE:ROQRoquefort Therapeutics Plc
09/27/20239:43AMAlliance NewsAlliance NewsEARNINGS: Biome loss widens; Amicorp focused on growth post-IPOLSE:ROQRoquefort Therapeutics Plc
09/27/20239:43AMAlliance NewsAlliance NewsEARNINGS: Biome loss widens; Amicorp focused on growth post-IPOLSE:ROQRoquefort Therapeutics Plc
09/27/20231:00AMUK RegulatoryRoquefort Therapeutics PLC Interim Results to 30 June 2023LSE:ROQRoquefort Therapeutics Plc
09/22/20235:42AMRNS Non-RegulatoryRoquefort Therapeutics PLC Investor Presentation via Investor Meet CompanyLSE:ROQRoquefort Therapeutics Plc
08/14/20235:07AMAlliance NewsAlliance NewsRoquefort files patent application for mRNA and RNA therapiesLSE:ROQRoquefort Therapeutics Plc
08/14/20235:07AMAlliance NewsAlliance NewsRoquefort files patent application for mRNA and RNA therapiesLSE:ROQRoquefort Therapeutics Plc
08/14/20231:00AMUK RegulatoryRoquefort Therapeutics PLC Expansion of Patent PortfolioLSE:ROQRoquefort Therapeutics Plc
08/07/20235:04AMAlliance NewsAlliance NewsIN BRIEF: Roquefort announces new sirNA sequences and patent filingLSE:ROQRoquefort Therapeutics Plc
08/07/20235:04AMAlliance NewsAlliance NewsIN BRIEF: Roquefort announces new sirNA sequences and patent filingLSE:ROQRoquefort Therapeutics Plc
08/07/20231:00AMUK RegulatoryRoquefort Therapeutics PLC Development of New Novel siRNA TherapeuticsLSE:ROQRoquefort Therapeutics Plc
 Showing the most relevant articles for your search:LSE:ROQ

Your Recent History

LSE
0O5P
Polenergia
BOV
T1WL34
Twilio
TG
A19QW5
ASR Nederland NV
USOTC
CHWTF
Coolpad (PK)
UNSW3
HARAMBEETH
Harambe
USOTC
TORCF
TinOne Resources (QB)
TSXV
NSY
NSX Silver Inc.
ASX
SACHA
Securitised Australian M...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved